Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 553-566

  Murphy, L C ^a,b   Peng, B ^a,b   Lewis, A ^a,b   Davie, J R ^a,b   Leygue, E ^a,b   Kemp, A ^b   Ung, K ^b   Vendetti, M ^a   Shiu, R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DOXYCYCLINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; PROGESTERONE RECEPTOR; TAMOXIFEN; TUBULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; EPITOPES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR PROBES; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; TAMOXIFEN; UP-REGULATION;

EID: 17844409085     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01688     Document Type: Article

References (61)

1. Adeyinka A, Niu Y, Cherlet T, Snell L, Watson P & Murphy L 2002 Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer rogression. Clinical Cancer Research 8 1747-1753.
2. Anderson E, Clarke R & Howell A 1998 Estrogen responsiveness and control of normal human breast proliferation. Journal of Mammary Gland Biology and Neoplasia 3 23-35.
3. Aronica S & Katzenellenbogen BS 1991 Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 128 2045-2052.
4. Bai Y & Giguere V 2003 Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and erbB-2 signaling in living cells. Molecular Endocrinology 17 589-599.
5. Biersack H, Bender H & Palmedo H 2004 FDG-PET in monitoring therapy of breast cancer. European Journal of Neuclear Medicine Molecular Imaging. Apr 27 [Epub ahead of printf]].
6. Clarke R, Howell A, Potten C & Anderson E 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Research 57 4987-4991.
7. Clarke R, Leonessa F, Welch J & Skaar T 2001 Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacological Reviews 53 25-71.
8. Clarke R, Liu M, Bouker K, Gu Z, Lee R, Zhu Y, Skaar T, Gomez B, O'Brien K, Wang Y et al. 2003 Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22 7316-7339.
9. Clemons M & Goss P 2001 Estrogen and the risk of breast cancer. New England Journal of Medicine 344 276-285.
10. Colditz G 1998 Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Journal of the National Cancer Institute 90 814-823.
11. Coutts A, Davie J, Dotzlaw H & Murphy L 1996 Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. Journal of Cellular Biochemistry 63 174-184.
12. Cowley S, Hoare S, Mosselman S & Parker M 1997 Estrogen receptors alpha and beta form heterodimers on DNA. Journal of Biological Chemistry 272 19858-19862.
13. Dotzlaw H, Leygue E, Watson P & Murphy L 1997 Expression of estrogen receptor-beta in human breast tumors. Journal of Clinical Endocrinology and Metabolism 82 2371-2374.
14. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M & Gustafsson J-A 1997 Human estrogen receptor β gene structure, chromosomal localization and expression pattern. Journal of Clinical Endocrinology and Metabolism 82 4258-4265.
15. Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson J-A & Rochefort H 2004 Estrogen receptor beta (ERbeta) level but not its ERbeta-cx variant helps to predict tamoxifen resistance in breast cancer. Clinical Cancer Research 10 5769-5776.
16. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M & Gustafsson J 2002 Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium. PNAS 99 15578-15583.
17. Fuqua S, Schiff R, Parra I, Friedrichs W, Su J, McKee D, Slentz-Kesler K, Moore L, Willson T & Moore J 1999 Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Research 59 5425-5428.
18. Fuqua S, Schiff R, Parra I, Moore J, Mohsin S, Osborne C, Clark G & Allred D 2003 Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Research 63 2434-2439.
19. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W & Bujard H 1995 Transcriptional activation by tetracyclines in mammalian cells. Science 268 1766-1769.
20. Hall J & McDonnell D 1999. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578.
21. Hewitt S, Deroo B, Hansen K, Collins J, Grissom S, Afshari C & Korach K 2003 Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Molecular Endocrinology 17 2070-2083.
22. Htun H, Holth L, Walker D, Davie J & Hager G 1999 Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Molecular Biology of the Cell 10 471-486.
23. Jarvinen T, Pelto-Huikko M, Holli K & Isola J 2000 Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. American Journal of Pathology 156 29-35.
24. Jensen E, Cheng G, Palmieri C, Saji S, Makela S, Noorden Sv, Wahlstrom T, Warner M, Coombes R & Gustafsson J-A 2001 Estrogen receptors and proliferation markers in primary and recurrent breast cancer. PNAS 98 15197-15202.
25. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. PNAS 93 5925-5930.
26. Kuiper G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson J-A 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 863-870.
27. Lazennec G, Bresson D, Lucas A, Chauveau C & Vignon F 2001 ERβ inhibits proliferation and invasion of breast cancer cells. Endocrinology 142 4120-4130.
28. Leygue E, Dotzlaw H, Watson P & Murphy L 1998a Altered estrogen receptor alpha and beta mRNA expression during human breast tumorigenesis. Cancer Research 58 3197-3201.
29. Leygue E, Dotzlaw H, Lu B, Glor C, Watson P & Murphy L 1998b Estrogen receptor-beta: mine is longer than yours? Journal of Clinical Endocrinology and Metabolism 83 3754-3755.
30. Lippman M & Bolan G 1975 Oestrogen responsive human breast cancer in long term tissue culture. Nature 256 592-593.
31. McDonnell D & Norris J 2002 Connections and regulation of the human estrogen receptor. Science 296 1642-1644.
32. Mann S, Laucirica R, Carlson N, Younes P, Ali N, Younes A, Li Y & Younes M 2001 estrogen receptor beta expression in invasive breast cancer. Human Pathology 32 113-118.
33. Miksicek R, Myal Y, Watson P, Walker C, Murphy L & Leygue E 2002 Identification of a novel mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Research 62 2736-2740.
34. Mortimer J, Dehdashti F, Siegel B, Trinkaus K, Katzenellenbogen J & Welch M 2001 Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. Journal of Clinical Oncology 19 2797-2803.
35. Murphy L & Watson P 2002 Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomedical Pharmacotherapy 56 65-77.
36. Murphy L, Leygue E, Niu Y, Snell L, Ho S-M & Watson P 2002 Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. British Journal of Cancer 87 1411-1416.
37. Murphy L, Cherlet T, Lewis A, Banu Y & Watson P 2003 New insights into estroven receptor function in human breast cancer. Annals of Medecine 35 614-631.
38. Myers E, Fleming F, Crotty T, Kelly G, McDermott E, O'Higgins N, Hill A & Young L 2004 Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer. British Journal of Cancer 91 1687-1693.
39. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y & Muramatsu M 1998a Molecular cloning and characterization of human estrogen receptor bcx: potential inhibitor of estrogen action in human. Nucleic Acids Research 26 3505-3512.
40. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orima A, Hosoi T, Ouchi Y & Muramatsu M 1998b The complete primary structure of human estrogen receptor β and its heterodimerization with ERα in vivo and in vitro. Biochemical and Biophysical Research Communications 243 122-126.
41. Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Gustafsson J & Iwase H 2002 Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. European Journal of Cancer 38 380-386.
42. Osborne C 1998 Steroid hormone receptors in breast cancer management. Breast Cancer Research and Treatment 51 227-238.
43. Paech K, Webb P, Kuiper G, Nilsson S, Gustafsson J, Kushner PJ & Scanlan TS 1997 Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 1508-1510.
44. Paruthiyil S, Parmar H, Kerekatte V, Cunha G, Firestone G & Leitman D 2004 Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Research 64 423-428.
45. Peng B, Lu B, Leygue E & Murphy L 2003 Putative functional characteristics of human estrogen receptor-beta isoforms. Journal of Molecular Endocrinology 30 13-29.
46. Plotkin D, Lechner J, Jung W & Rosen P 1978 Tamoxifen flare in advanced breast cancer. Journal of the American Medical Association 240 2644-2646.
47. Read L, Snider C, Miller J, Greene G & Katzenellenbogen B 1988 Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Molecular Endocrinology 2 263-271.
48. Roger P, Sahla M, Makela S, Gustafsson JA, Baldet P & Rochefort H 2001 Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Research 61 2537-2541.
49. Saunders A, Millar M, Williams K, Macpherson S, Bayne C, O'Sullivan C, Anderson T, Groome N & Miller W 2002 Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies. British Journal of Cancer 86 250-256.
50. Skliris G, Munot K, Bell S, Carder P, Lane S, Horgan K, Lansdown M, Parkes A, Hanby A, Markham A et al. 2003 Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model. Journal of Pathology 201 213-220.
51. Speirs V 2002 Oestrogen receptor beta in breast cancer: good, bad or still too early to tell? Journal of Pathology 197 143-147.
52. Speirs V, Malone C, Walton D, Kerin M & Atkin S 1999 Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Research 59 5421-5424.
53. Stossi F, Barnett D, Fraser J, Komm B, Lyttle C & Katzenellenbogen B 2004 Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145 3473-3486.
54. Strom A, Hartman J, Foster J, Kietz S, Wimalasena J & Gustafsson J-A 2004 Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. PNAS 101 1566-1571.
55. Tonetti D, Rubenstein R, Deleon M, Zhao H, Pappas S, Bentrem D, Chen B, Constantinou A & Jordan V 2003 Stable transfection of an estrogen receptor beta cDNA isofrm into MDAMB231 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 87 47-55.
56. Venditti M, Iwasiow B, Orr F & Shiu R 2002 C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. International Journal of Cancer 99 35-42.
57. Vogel C, Schoenfelder J, Shemano I, Hayes D & Gams R 1995 Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. Journal of Clinical Oncology 13 1123-1128.
58. Weihua Z, Saji S, Makinen S, Cheng G, Jensen E, Warner M & Gustaffson J-A 2000 Estrogen receptor (ER)β, a modulator of ERα in the uterus. PNAS 97 5936-5941.
59. Wijayaratne A & McDonnell D 2001 The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. Journal of Biological Chemistry 276 35684-35692.
60. Yang S, Liu R, Perez E, Wen Y, Stevens S, Valencia T, Brun-Zinkernagel A, Prokai L, Will Y, Dykens J et al. 2004 Mitochondrial localization of estrogen receptor beta. PNAS 101 4130-4135.
61. Zhao H, Hart L, Keller U, Holth L & Davie J 2002 Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells. Journal of Cellular Biochemistry 86 365-375.